End-to-end Outsourcing IA offers end-to-end statistical analysis, clinical programming, data management, data reporting and medical writing for the full clinical development life cycle, enabling sponsors to outsource the entire project to a single partner and maintain transparent project visibility. They can also supply a virtual development team to coordinate resources with other providers.

Experienced Specialists Leverage a highly experienced team with deep domain knowledge and CCDM certified lead data managers to de-risk projects and ensure on-time, regulatory compliant deliverables in drug and device development.

Flexible Collaboration Flexible collaboration with the ability to act as a virtual drug development team, pairing data management, statistics, programming, and medical writing with other service providers to support protocol design through study report writing, and to scale for biomarker, imaging, pharmacogenomics, and molecular diagnostics initiatives.

Value and Transparency Value driven delivery model emphasizing on-time deliverables, transparent project management, innovative cost-effective solutions, and honest issue resolution to reduce vendor risk and total cost of ownership.

Biotech Growth Focus Target growth opportunities in emerging biotech areas such as biomarker identification and validation, clinical imaging, pharmacogenomics and molecular diagnostics, appealing to mid-size pharma and biotech firms seeking specialized analytics without engaging large CROs.